Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — H1 2026 Earnings Presentation
22 slides from Trendlines's earnings presentation, August 2026
Slide 1: Succeeding Together
Succeeding Together Transforming futures in medtech & agrifood August 2026
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: Who we are
The Trendlines Group (SGX: 42T; OTCQX: TRNLY) invests in agrifood and medtech innovative companies from seed to market. Based in Israel and Singapore, we combine capital, expertise, and partnerships to drive impactful technologies, empower entrepreneurs, and create long-term value for our investors
Slide 4: Leadership
Leadership Haim Brosh Barak Singer Orit Alaluf Cohen Executive Director & Executive VP & Head of Chief Financial Officer Steve Rhodes CEO Healthcare Founder & Chair Emeritus 25 years’ managerial Broad experience in all Trendlines’ Founder; over and financial Extensive investment financial functions,
Slide 5: Board of Directors
Board of Directors Nehama Ronen Sin Boon Ann Haim Brosh Independent Chair Independent Director Executive Director & CEO 25 years’ experience in public companies. 30 years’ experience 25 years’ managerial She was Director working in the legal and financial General of Israel’s industry and serving exp
Slide 6: A taste of our portfolio
A taste of our portfolio 31 portfolio companies 8 23 agrifood medtech 6
Slide 7: Portfolio cluster values
Portfolio cluster values Non-IFRS* Value of Trendlines’ Share Fair Value of Trendlines’ Share Cluster (US$ thousands) (additional information) (US$ thousands) 30.06.2026 30.06.2026 Aquaculture & Animal Health US$ 1,336 US$ 1,492 Crop Protection US$ 5,860 US$ 11,428 Future Food & Ingredients US$ 15,4
Slide 8: The natural food color revolution
The natural food color revolution A broad-spectrum of healthy plant-based colors produced via fermentation technology, using baker’s yeast as a biofactory. Founded 2018; Phytolon’s high-quality and cost-effective pigments offer value for Yokne’am Illit, IL consumers, the environment and food industr
Slide 9: 4 more agrifood frontrunners
4 more agrifood frontrunners 8 agrifood portfolio companies Phage-based solutions for crop Cultivating high quality and high Nanobody-based biological insect Oral delivery platform for the disease control that target bacteria value cocoa ingredients using cell control to uniquely target the preventi
Slide 10: Cryotherapy treatment for urological non-muscle invasive bladder cancer (NIMBC)
Cryotherapy treatment for urological non- muscle invasive bladder cancer (NIMBC) A new ablative approach for the treatment of urological tissue with cryotherapy. Founded 2015 CEO Eyal Kochavi Achievements IP Submitted national • Closed US$16.5 million investment round including phase and PCT strateg
Slide 11: 4 more leading medtech companies
4 more leading medtech companies 23 medtech portfolio companies Minimally invasive, nonsurgical, Endoscopic ultrasound fine needle Next-generation aspiration catheter A small, game-changing incision-free and mesh-free repair biopsy system for improve, precise for treating ischemic stroke. device to
Slide 12: H1 2026 financial report
H1 2026 financial report 12
Slide 13: Balance sheet
Balance sheet Assets (US$’000) Liabilities & Equity (US$’000) Current assets 30 June 2026 31 Dec 2025 Current liabilities 30 June 2026 31 Dec 2025 Cash and cash equivalents 830 4,817 Lease liability 221 271 Short-term bank deposits 4,183 110 Short-term loan 1,444 1,414 Trade and other payables 1,247
Slide 14: Profit and Loss Statements
Profit and Loss Statements (US$’000) Income 30 June 2026 30 June 2025 Gain/(Loss)from change in fair value of investments in portfolio companies 5,616* (392) Income from services to portfolio companies 113 307 Income from contracted R&D services - 84 Financial income 81 243 Other income 100 398 Tota
Slide 15: 2026 Corporate Updates
2026 Corporate Updates • Raised ~S$5.6 million for Trendlines in a private placement, including participation of an institutional investor. • Deconsolidation of the Singapore portfolio companies where these investments are now measured at fair value. 15
Slide 16: 2026 Portfolio Achievements
2026 Portfolio Achievements • Significant portfolio progress: ✓ Phytolon • FDA clearances in progress • Completed Series B round of US$23.6 million ✓ Celleste • Unveiled first chocolate bar made from cell-cultured cocoa butter • Raised US$5 million ✓ Escala • Commercialization in the US with growing
Slide 17: 2026 Portfolio Achievements
2026 Portfolio Achievements • Significant portfolio progress: ✓ Vessi • On going new clinical study in Spain and Israel with positive results ✓ IBI-Ag • Successful development of AI-Driven de novo protein design platform for bioinsecticides ✓ ElastiMed • Exclusive U.S. Distribution Agreement with Ta
Slide 18: 2026 Portfolio Achievements
2026 Portfolio Achievements • Significant portfolio progress: ✓ Ceretrieve • Ongoing new clinical study in Europe (Germany, Portugal) with successful results in more than 35 patients. ✓ Vensica • Received FDA IND clearance to initiate Phase 2 study of ViXe, its needle-free Xeomin® delivery system fo
Slide 19: Thank you
THANK YOU +972.72.260.7000 | www.trendlines.com
Slide 20: Notes and Disclaimer
Notes and Disclaimer The non-IFRS fair value information does not represent any forecast or future performance but serves as an extra aid in evaluating our portfolio companies and investment approaches. The additional information (Non-IFRS value) which, as stated, differs from the IFRS fair value at
Slide 21: Financial Statements and Related Announcement: Half Yearly Results
05/08/2026, 18:57 Financial Statements and Related Announcement::Half Yearly Results FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS Issuer & Securities Issuer/ Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. - 1L0011328858 - 42T Stapled Security No Announce
Slide 22: Financial Statements and Related Announcement: Half Yearly Results
05/08/2026, 18:57 Financial Statements and Related Announcement::Half Yearly Results Attachments gS Trendlines - H1 2026 Announcement.pdf gS Trendlines H1 2026 Results Press Release .pdf gS Trendlines Presentation H1 2026 .pdf Total size =3294K MB https://links.sgx.com/1 .0.0/corporate-announcements